文献速递神经免疫

日本儿童抗NMDAR脑炎诊断标准评估

Evaluation of the Diagnostic Criteria for Anti-NMDA Receptor Encephalitis in Japanese Children.
PubMed 文献 · Neurology · 2021-03-02

该研究回顾性分析了2015至2019年日本137例送检脑脊液NMDAR抗体的神经系统症状患儿,评估2016年儿童可能抗NMDAR脑炎临床诊断标准的有效性。标准敏感度81.2%、特异度76.9%、阳性预测值31.7%、阴性预测值96.9%,假阳性组男性更多且多与神经自身免疫相关。结论认为标准可用于启动免疫调节治疗,但需继续鉴别诊断。

要点

  • 2016年儿童可能抗NMDAR脑炎诊断标准敏感度81.2%、特异度76.9%。
  • 标准阳性预测值仅31.7%,阴性预测值高达96.9%。
  • 假阳性诊断者男性更多,且多与神经自身免疫相关。

核心结论

  • 该临床诊断标准对标准阳性病例启动免疫调节治疗是可靠的。
  • 低阳性预测值可能源于儿童人群中NMDAR脑炎患病率较低或对脑炎怀疑度较低。
  • 医生应继续鉴别诊断,尤其关注其他形式的脑炎。

研究设计与样本

  • 回顾性队列研究,纳入2015年1月1日至2019年3月31日在其实验室进行脑脊液NMDAR抗体检测的神经系统症状患者,共137例。

主要发现

  • 41例标准阳性中13例抗体阳性、28例抗体阴性;96例标准阴性中3例抗体阳性、93例抗体阴性。
  • 标准敏感度81.2%、特异度76.9%、阳性预测值31.7%、阴性预测值96.9%。
  • 假阳性组男性比例高于真阳性组(真阳性男:女=4:9,假阳性男:女=19:9,p=0.0425)。
  • 大多数假阳性诊断病例与神经自身免疫相关。

关键数值与推荐

  • 敏感度81.2%,特异度76.9%,阳性预测值31.7%,阴性预测值96.9%。
  • 真阳性组男:女=4:9,假阳性组男:女=19:9,p=0.0425。

临床怎么用

  • 对符合2016年标准的儿童病例可依据标准启动免疫调节治疗。
  • 标准阴性预测值高,阴性结果有助于排除抗NMDAR脑炎。
  • 因阳性预测值低,标准阳性者仍需重点鉴别其他类型脑炎。

局限性

  • 研究为回顾性设计,证据等级为Class IV。
  • 样本来自单一实验室送检人群,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the validity of the 2016 clinical diagnostic criteria proposed for probable anti-NMDA receptor (NMDAR) encephalitis in children, we tested the criteria in a Japanese pediatric cohort. METHODS: We retrospectively reviewed clinical information of patients with neurologic symptoms whose CSF was analyzed for NMDAR antibodies (NMDAR-Abs) in our laboratory from January 1, 2015, to March 31, 2019. RESULTS: Overall, 137 cases were included. Of the 41 cases diagnosed as probable anti-NMDAR encephalitis (criteria-positive) according to the 2016 criteria, 13 were positive and 28 were negative for anti-NMDAR-Abs. Of the 96 criteria-negative cases, 3 were positive and 93 were negative for anti-NMDAR-Abs. The sensitivity of the criteria was 81.2%, specificity was 76.9%, positive predictive value (PPV) was 31.7%, and negative predictive value was 96.9%. Compared with the true-positive group, the false-positive group contained more male than female patients (male:female, 4:9 in the true-positive vs 19:9 in the false-positive group, p = 0.0425). The majority of the cases with false-positive diagnoses were associated with neurologic autoimmunity. CONCLUSION: The clinical diagnostic criteria are reliable for deciding to start immunomodulatory therapy in the criteria-positive cases. Low PPV may be caused by a lower prevalence of NMDAR encephalitis or lower level of suspicion for encephalitis in the pediatric population. Physicians should therefore continue differential diagnosis, focusing especially on other forms of encephalitis. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that the proposed diagnostic criteria for anti-NMDAR encephalitis in children has a sensitivity of 81.2% and a specificity of 76.9%.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Nishida H, Kohyama K, Kumada S, et al. Evaluation of the Diagnostic Criteria for Anti-NMDA Receptor Encephalitis in Japanese Children. Neurology. 2021. PMID: 33653900. doi:10.1212/WNL.0000000000011789

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。